Clinical & Experimental Cardiology
Open Access

Selection of Serum Biomarkers for Persistent Angina

Stefania Angela^{* *}Correspondence: Stefania Angela, Department of Cardiology, University of Bologna, Bologna, Italy, Email:

Author info »

Description

Although the danger of Unstable Angina (UA), a kind of Coronary Heart Disease (CHD) with significant mortality and morbidity worldwide, is evident from statistical evidence, it is crucial to understand that the condition has poor diagnostic accuracy. The use of 1H NMR-based blood metabolic profiling to examine the metabolic fingerprints of Unstable Angina Pectoris (UAP), which is a reliable method for making a medical diagnosis and gaining insight into potential biomarkers. Effective separation between the UAP and control groups was observed, and when the serum concentrations of the former group were compared to those of their counterpart, Lac, m-I, lipid, VLDL, 3- HB, and LDL were higher while those of Thr, Cr, Cho, PC/ GPC, Glu, Gln, Lys, HDL, Ile, Leu, and Val were lower. According to the findings, the plasma metabolomics studied by 1H NMR showed potential for the discovery of UA biomarkers. Unstable Angina Pectoris (UAP) is a common consequence of Coronary Heart Disease (CHD), and in industrialized countries, one-third of the population develops the condition before the age of 70.

Over one million people are hospitalized as a result of it annually, and it is a major cause of patient fatalities. The illness is characterized by varieties of clinical manifestations that are brought on by a blockage in the coronary flow. Such obstructions may result from a number of pathophysiological causes, the most common of which being the rupture of intracoronary athermanous plaques, platelet aggregation, and thrombus development. At the moment, angina symptoms and changes to the ECG are used to diagnose UA. However, it is critical to be aware of this approach's shortcomings, which mostly stem from the lack of impartiality regarding symptoms and the nature of ECG variation. Despite the knowledge that coronary angiography has high diagnostic reliability and accuracy for UA, some people are unwilling to undertake it because it requires an invasive procedure. Patients' symptoms, which appear as high cholesterol, triglyceride-rich lipoprotein particles (mainly VLDL and LDL), and reduced cholesterol levels in HDL particles, are important factors to take into account when diagnosing UAP in clinical practice. It is crucial to remember that not all UA patients experience greater levels, and that higher levels can also occur in people with various types of CHD. Studies have shown that metabolite irregularities in human tissues and fluids are related to the aetiology of a number of health problems. The quantitative evaluation of small molecule metabolites within an organism is made easier by metabolomics, and the technique can be used to analyze how the concentration of particular metabolites changes in response to pathophysiological stimuli. HNuclear Magnetic Resonance Spectroscopy (H-NMR) has been used to diagnose CHD, and it makes it easier to compare the levels of many endogenous and exogenous molecules. As a result, the literature reports that the process has a significant impact on the analysis of physiological status, condition diagnosis, biomarker identification, and the discovery of the pathways affected by disease or treatment.

High-resolution NMR spectroscopy is one of the most important quantitative and non-destructive methods used in clinical settings. It is regarded favorably since it is reliable and robust and can be replicated and repeated. This method has recently produced encouraging results in the search for biomarkers for cardiovascular diseases like myocardial ischemia, heart failure, and hypertension. Serum is an excellent biological fluid for medical exams since it may be easily acquired from individuals of all ages. In the new analysis, 1H NMR is used to analyze blood samples taken from UAP patients and healthy volunteers who have already had their coronary angiography diagnosis and confirmation. In light of physiological and pathological variations, variations in metabolite profiles are noted in relation to the serum of each group. It is crucial to understand that advanced characterization and authentication using a significant sample size could facilitate their establishment as clinically useful biomarkers.